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a b s t r a c t
Depressed pregnant women (N=126) were divided into high and low prenatal maternal
dopamine (HVA) groups based on a tertile split on their dopamine levels at 20 weeks
gestation. The high versus the low dopamine group had lower Center for Epidemiologi-
cal Studies-Depression Scale (CES-D) scores, higher norepinephrine levels at the 20-week
gestational age visit and higher dopamine and serotonin levels at both the 20- and the
32-week gestational age visits. The neonates of the mothers with high versus low prenatal
dopamine levels also had higher dopamine and serotonin levels as well as lower corti-
sol levels. Finally, the neonates in the high dopamine group had better autonomic stability
and excitability scores on the BrazeltonNeonatal Behavior Assessment Scale. Thus, prenatal
maternal dopamine levels appear to be negatively related to prenatal depression scores and
positively related to neonatal dopamine and behavioral regulation, although these effects
are confounded by elevated serotonin levels.
© 2008 Elsevier Inc. All rights reserved.
1. Prenatal dopamine and depression
Human and animal studies suggest a relationship between dopamine transmission and depression (Dailly, Chenu, Renard,
&Bourin, 2004 for a review). At least one studyhas reported lower dopamine levels in depressedpregnantwomen (Field et al.,
2004). In that study, the newborns of depressed mothers also had low dopamine levels. Low dopamine has been implicated
in lower orienting behavior in 2-week-old infants andmore negative temperament in 2-month-old infants (Auerbach, Faroy,
Ebstein, Kahana, & Levine, 2001) as well as less exploratory behavior in 1-year-old infants (Ebstein et al., 1998). These data
suggest that low dopamine is a marker of less optimal infant development and that prenatal maternal depression and low
dopamine levels may be precursors to infants’ developmental delays.
The relationship between dopamine and depression is complicated, however, by dopamine’s interaction with several
other neurotransmitters including serotonin and norepinephrine (Kalia, 2005). As several have noted, the norepinephrine,
dopamine and serotonin systems have reciprocal interactions,making it difﬁcult to act on a speciﬁc systemwithout a cascade
of events affecting the other two systems (Trivedi, 2006). One research group has reported an interaction between serotonin
and dopamine (Esposito, 2006), and another study has documented an interaction between dopamine and norepinephrine
(Nutt, 2006).
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Further, cortisol hypersecretion in depressed patients has been correlated with dopaminergic dysfunction (Duval et al.,
2006). In this study, chronic elevation of cortisol led to dopaminergic and noradrenergic dysfunction. Others have reported
that patients who had high plasma cortisol levels had low dopamine levels (Mitani, Shirayama, Yamada, & Kawahara, 2006).
The purpose of the present study was to determine the effects of high prenatal dopamine levels on prenatal maternal
depression and on other neurotransmitters during pregnancy and to assess neonatal biochemical and behavioral differences
related tohighprenatal dopamine levels.No literature couldbe foundon theeffects of dopamine levels onprenatal depression
except the research alreadynoted fromour lab (Field et al., 2004). In that longitudinal follow-upof a large sample of prenatally
depressed women, we noted elevated cortisol and norepinephrine and low levels of serotonin and dopamine. In turn, the
biochemical proﬁle noted in the prenatally depressed women was also evident in their neonates (Field et al., 2004).
To assess the effects of dopamine levels on prenatal depression and neonatal outcome, the pregnantwomen in the present
study were divided into the top and bottom tertiles based on their dopamine levels at 20 weeks gestational age. The higher
prenatal maternal dopamine groupwas expected to have higher prenatal serotonin and lower cortisol levels as well as lower
depression scores. The clinical relevance of this study was the assessment of potential biochemical markers for negative
pregnancy outcomes.
2. Method
2.1. Participants
The participants were 126 depressed pregnant women. The women averaged 25 years of age, their socioeconomic status
was low to middle (M=3.3 on the Hollingshead index), they were distributed 55% Hispanic, 35% Black and 10% White, and
30% were married. The high and low dopamine groups did not differ on these demographic variables.
2.2. Procedure
Thepregnantwomenwere recruitedatprenatal clinicsduring theirﬁrstultrasoundvisit (M=20weeksgestation,R=16–22
weeks). Following informed consent, thepregnantwomenwere given the StructuredClinical Interview forDepression (SCID).
Although illicit drug use was an exclusionary criterion, none of the women reported this problem when questioned about
drug use during the background interview. Thewomenwere assessed at 20weeks and again at 32weeks gestation, and their
infants were evaluated for biochemical and behavioral proﬁles at the neonatal period (M=2 days). The assessments were
made by research associates who were “blind” to the women’s group assignment.
2.2.1. Structured Clinical Interview for DSM-IV Disorders (SCID)
All women in the study were given the research version of the SCID (more structured version) at the 20-week gesta-
tion period to determine depression and anxiety diagnoses and to screen out other disorders including bipolar disorder,
schizophrenia and other psychotic disorders. The women were diagnosed with Dysthymia or Major Depression on the SCID
based on DSM-IV symptoms. Both depression types (Major Depression and Dysthymia) and those diagnosedwith co-morbid
anxiety disorder were eligible for the study. The SCID was administered by research associates following training and with
continuing on site supervision by a clinical psychologist. In our experience (including a recent survey sample), the majority
of the depressed pregnant women who attend the university ultrasound clinic were not taking anti-depressants and were
not receiving other treatments for depression.
2.2.2. The Center for Epidemiological Studies-Depression Scale (CES-D)
This is a 20-item scale that assesses the frequency of depressive symptoms within the last week (Radloff, 1977). With
scores ranging from 0 to 60, a cut-off score of 16 is used for classifying a major depressive episode. With only a 6% false
positive and 36% false negative rate (Myers &Weissman, 1980), this scale has been shown to be reliable and valid for diverse
demographic groups and has been successfully used as a self-report assessment of depression in a number of studies that
involved similar populations (e.g., Diego et al., 2004). This scale was given at the 20-week gestation period.
2.2.3. Urinary catecholamines and metabolites
Urinary sampleswere collected from thewomen at the beginning of the 20- and 32-week gestation visits atmid-morning
and fromtheneonateswithin theﬁrst2dayspost-delivery.Nosystematicdifferenceswerenoted in the samplingor the timing
of collection of urine samples between women. Urine samples were transferred to plastic vials and frozen without using
acid or other preservatives. Assays were conducted by high-pressure liquid chromatography (HPLC) with electrochemical
detection (Kilts, Gooch, & Knopes, 1984). Urinary levels of the dopamine metabolite, the serotonin metabolite, and the
norepinephrinemetaboliteweremeasured, as themajority of excreted dopamine and serotonin respectively exist in the form
of metabolites. Urinary cortisol was assayed in the stored urine samples by radioimmunoassay using a speciﬁc antiserum
from Radioassay Systems Laboratories (Carson City, CA).
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Table 1
Means for self-report and biochemical variables for pregnantwomen divided into top and bottom (high and low) tertiles on prenatal dopamine (HVA) levels
(S.D.s in parentheses)
Low dopamine High dopamine F p
Self-report variables
Depression (CES-D) 19.6 (10.4) 16.3 (10.0) 4.01 .05
Somatic-vegetative subscale (CES-D) 9.5 (2.1) 6.3 (1.5) 5.05 .05
Biochemical values (20 weeks GA)
Dopamine 160.0 (63.6) 422.4 (102.1) 482.20 .000
Serotonin 3483.9 (2041.4) 4804.9 (2389.7) 13.92 .000
Norepinephrine 47.1 (22.4) 64.8 (26.1) 27.07 .000
Cortisol 230.8 (153.0) 238.3 (104.8) NS
Biochemical values (32 weeks GA)
Dopamine 187.7 (90.8) 299.6 (163.4) 15.23 .000
Serotonin 2833.1 (1730.9) 3836.0 (1978.6) 4.60 .04
Norepinephrine 45.3 (25.5) 54.1 (22.0) NS
Cortisol 267.3 (136.1) 277.6 (133.3) NS
Table 2
Means for biochemical values and behavioral variables for neonates of women who were divided into top and bottom (high and low) tertiles on their
prenatal dopamine (HVA) levels (S.D.s in parentheses)
Low dopamine High dopamine F p
Neonatal biochemical values
Dopamine 278.3 (141.7) 690.1 (193.9) 126.44 .00
Serotonin 6464.9 (4731.0) 10469.6 (6668.1) 6.37 .02
Norepinephrine 62.4 (36.3) 73.5 (47.9) NS
Cortisol 558.0 (189.0) 426.5 (196.2) 10.02 .002
Neonatal behavioral variables
Autonomic Stability 3.42 (.57) 4.75 (.96) 4.19 .05
Excitabilitya 2.50 (1.33) 1.90 (.93) 4.86 .05
a Lower score is optimal.
2.2.4. Brazelton Neonatal Behavior Assessment Scale
The Brazelton Neonatal Behavior Assessment Scale (BNBAS) (Brazelton, 1978) was given midway between feedings. The
scale is comprised of 20 neurological reﬂex items and 27 other items summarized according to 7 factors: habituation,
orientation, motor behavior, range of state, state regulation, autonomic stability and abnormal reﬂexes. In addition, scores
are given for excitability and depressive behaviors. The Brazelton examiners were unaware of the infant’s group assignment
and were trained to a .90 reliability criterion prior to the study.
3. Results
As can be seen in Table 1, ANOVA comparisons between high and low dopamine groups based on a tertile split yielded
the following for the high (N=42) versus low (N=42) dopamine group: (1) lower CES-D depression and somatic-vegetative
subscale scores (eating and sleep problems) at the 20-week gestational age period; (2) higher dopamine, serotonin and nore-
pinephrine levels at the 20-week gestational age visit; (3) higher dopamine and serotonin levels at the 32-week gestational
age visit. As can be seen in Table 2, the neonates of high dopamine mothers had: (1) higher dopamine and serotonin levels;
(2) lower cortisol levels; (3) better scores on the autonomic stability and excitability subscales of the Brazelton Neonatal
Behavior Assessment Scale, although the groups did not differ on the other Brazelton Subscales.
4. Discussion
These data are consistent with previous data on non-pregnant adults, showing that depression scores were higher in
those with lower dopamine levels (Netter, 2006). A greater number of somatic/vegetative symptoms as reported by these
pregnant women on the CES-D subscale are also consistent with the proﬁle of anhedonia, apathy and dysphoria that has
been associated with dopaminergic hypofunction (Bressan & Crippa, 2005).
The simultaneously elevated serotonin in the pregnant womenwith elevated dopamine was consistent across pregnancy
(20 and 32 weeks gestation), and is consistent with the interactive phenomena as reported by many (Esposito, 2006; Nutt,
2006; Trivedi, 2006). As Trivedi (2006) noted, the interactions of the dopamine, norepinephrine and serotonin systems
suggest that one system affects the others, confounding the effects of each other. A similar interaction has been noted
between cortisol and dopamine, with hypersecretion of cortisol being correlated with dopaminergic dysfunction (Duval et
al., 2006; Mitani et al., 2006). Surprisingly, cortisol was not elevated in this group of pregnant women, although elevated
cortisol was noted in the depressed pregnant women in our earlier study (Field et al., 2004). The neonates of high dopamine
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mothers had similarly higher dopamine and serotonin levels but also the expected lower cortisol levels based on the negative
relationship noted between dopamine and cortisol in depressed adults (Duval et al., 2006;Mitani et al., 2006). The similarity
between mothers’ prenatal biochemical proﬁles and those of their neonates has been noted in other samples of depressed
women by our group (Field et al., 2004; Lundy, Field, Cigales, Cuadra, & Pickens, 1997).
That the infants of high dopamine mothers had better autonomic stability and less excitability may relate to their own
dopamine levels being high. These ﬁndings are consistent with the data showing better temperament (less negative emo-
tionality) in 2-month-old infants and less anger in 12-month-old-infants (duringmild physical restraint)who have increased
dopamine receptors (Auerbach et al., 2001). However, the absence of group differences on the Brazelton orientating subscale
was surprising given that high dopamine infants have also been reported to have better orienting scores at 2 weeks and
more exploratory behavior at 12-months (Ebstein et al., 1998). Finally, greater rates of learning (habituation) in infancy (at
3-months) and greater novelty seeking in adolescence have been associated with greater numbers of dopamine receptors
(Laucht, Becker, & Schmidt, 2006).
In summary, low prenatal maternal dopamine levels may be a marker for low dopamine levels in the neonate and a
risk factor for later negative temperament and cognitive delays. These data suggest that prenatal urine samples could be
assayed for these biochemical markers, and, together with CES-D scores, they could be used to identify at-risk pregnancies.
Further research, however, is needed to assess these biochemical interactions and their longer-term effects as well as any
interventions that might alter these proﬁles during pregnancy.
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